A functional disturbance in the auditory cortex related to a low serotonergic neurotransmission in women with type 2 diabetes

Neuroendocrinology

Volumn 86, Issue 4, 2007, Pages 289-294

  Manjarrez, Gabriel ^a   Vazquez, Felipe ^a   Delgado, Margarita ^a   Herrera, Rocio ^a   Hernandez, Jorge ^b  

^a HOSPITAL DE ESPECIALIDADES   (Mexico)

^b DEPARTAMENTO DE FÍSICA   (Mexico)

Author keywords

Auditory evoked potential (N1 P2) component; L Tryptophan; Serotonin; Type 2 diabetes

Indexed keywords

AMINO ACID; FATTY ACID; GLIBENCLAMIDE; METFORMIN; TRYPTOPHAN;

ADULT; ANALYTIC METHOD; ARTICLE; AUDITORY CORTEX; AUDITORY STIMULATION; CLINICAL ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; DIABETIC PATIENT; EVOKED AUDITORY RESPONSE; FEMALE; HUMAN; LATENT PERIOD; NEUROTRANSMISSION; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; PRIORITY JOURNAL; SEROTONINERGIC SYSTEM;

ACOUSTIC STIMULATION; AUDITORY CORTEX; DIABETES MELLITUS, TYPE 2; EVOKED POTENTIALS, AUDITORY; FEMALE; HUMANS; MIDDLE AGED; SEROTONIN; SYNAPTIC TRANSMISSION;

EID: 36248998852     PISSN: 00283835     EISSN: None     Source Type: Journal    
DOI: 10.1159/000109375     Document Type: Article

References (46)

1. Shih DQ, Stoffel M: Molecular etiologies of MODY and other early-onset forms of diabetes. Curr Diab Rep 2002;2:125-134.
2. Kahn SE: The relative contributions of insulin resistance and beta-cell dysfunction to the pathophysiology of type 2 diabetes. Diabetologia 2003;46:13-19.
3. Leahy JL: Pathogenesis of type 2 diabetes mellitus. Arch Med Res 2005;36:197-209.
4. Gispen WH, Biessels GJ: Cognition and synaptic plasticity in diabetes mellitus. Trends Neurosci 2000;23:542-549.
5. Hissa MN, D'Almeida JAC, Cremasco F, De Bruin VMS: Event related P300 potential in NIDDM patients without cognitive impairment and its relationship with previous hypoglycemic episodes. Neuroendocrinol Lett 2002;23:226-230.
6. Manjarrez GG, Herrera MJR, Molina HA, Bueno SS, González RM, Hernández RJ: Alteraciones de la neurotransmisión serotoninérgica cerebral inducida por diabetes mellitus tipo 1. Rev Invest Clín 1999;51:293-302.
7. Manjarrez GG, Herrera MJR, Bueno SS, González RM, Hernández RJ: Cambios en la biosíntesis de serotonina cerebral en ratas con diabetes mellitus inducida por estreptozotocina: efecto del tratamiento con insulina. Rev Invest Clín 2000;52:509-516.
8. Herrera R, Manjarrez G, Hernández J: Inhibition and kinetic changes of brain tryptophan-5-hydroxylase during insulin-dependent diabetes mellitus in the rat. Nutr Neurosci 2005;8:57-62.
9. Herrera R, Manjarrez G, Nishimura E, Hernández J: Serotonin-related tryptophan in children with insulin-dependent diabetes. Pediatr Neurol 2003;28:20-23.
10. Manjarrez G, Herrera R, Leon M, Hernández J: A low brain serotonergic neurotransmission in children with type 1 diabetes detected through the intensity dependence of auditory evoked potentials. Diabetes Care 2006;29:73-77.
11. Oldendorf WH: Brain uptake of radiolabeled amino acids, amines and hexoses after arterial injection. Am J Physiol 1971;221:1629-1639.
12. Hegerl U, Juckel G: Intensity dependence of auditory evoked potentials as an indicator of central serotonergic neurotransmission: a new hypothesis. Biol Psychiatry 1993;33:173-187.
13. Manjarrez GG, Hernandez ZE, Robles OA, Gonzalez RM, Hernandez RJ: Developmental impairment of auditory evoked N1/P2 component in rats undernourished in utero: its relation to brain serotonin activity. Dev Brain Res 2001;127:149-155.
14. Manjarrez GG, Cisneros I, Herrera MR, Robles OA, Vazquez EF, Hernández RJ: Prenatal impairment of brain serotonergic transmission in infants. J Pediatr 2005;147:592-596.
15. The Expert Committee on the Diagnosis and Classification of Diabetes Mellitus: Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Diabetes Care 2000;23(suppl 1):S4-S19.
16. Juckel G, Molnár M, Hegerl U, Csépe V, Karmos G: Auditory-evoked potentials as indicator of brain serotonergic activity - first evidence in behaving cats. Biol Psychiatry 1997;41:1181-1195.
17. Semple MN, Scott BH: Cortical mechanisms in hearing. Curr Opin Neurobiol 2003;13:167-173.
18. Peat MA, Gibb JW: High-performance liquid chromatography determination of indoleamines, dopamine, and norepinephrine in rat brain with fluorometric detection. Anal Biochem 1983;128:275-280.
19. Doumas BT, Watson WA, Biggs HG: Albumin standards and the measurement of serum albumin with bromocresol green. Clin Chim Acta 1971;31:87-96.
20. Bentley R: Glucose oxidase in the enzymes; in Boyer PD (ed): The Enzymes. New York, Academic Press, 1963, pp 567-586.
21. Cole RA, Soeldner JS, Dunn PJ: A rapid method for the determination of glycosylated hemoglobin using high-pressure liquid chromatography. Metabolism 1978;27:289-301.
22. Einarsson S, Josefsson B, Lagerkvist S: Determination of amino acids with 9-fluronylmethylcholoroformate and reversed-phase high-performance liquid chromatography. J Chromatogr 1983;282:609-618.
23. Gastaldelli A, Miyazaki Y, Pettiti M, Matsuda M, Mahankali S, Santini E, DeFronzo RA, Ferrannini E: Metabolic effects of visceral fat accumulation in type 2 diabetes. J Clin Endocrinol Metab 2002;87:5098-5103.
24. Griffiths M, Payne PR, Stunkard AJ, Rivers JP, Cox M: Metabolic rate and physical development in children at risk of obesity. Lancet 1990;336:76-78.
25. Boden G: Interaction between free fatty acids and glucose metabolism. Curr Opin Clin Nutr Metab Care 2002;5:545-549.
26. Lam TK, Carpentier A, Lewis GF, Van De Werve G, Fantus IG, Giacca A: Mechanisms of the free fatty acid-induced increase in hepatic glucose production. Am J Physiol Endocrinol Metab 2003;284:E863-E873.
27. McMenamy RH, Oncley JL: The specific binding of L -tryptophan to serum albumin. J Biol Chem 1975;233:1436-1447.
28. Pardridge WM: Tryptophan transport through the blood-brain barrier: in vivo measurement of free and albumin-bound amino acid. Life Sci 1979;25:1519-1528.
29. Garber ZM: Las características de interacción y de unión del triptofano con la albúmina plasmática en ratas normales y con desnutrición ontogénica;tesis de licenciatura en nutrición y ciencias en los alimentos, Universidad Iberoamericana, México City, 1993, p 65.
30. Hernandez RJ, Meneses HL, Manjarrez GG: Another abnormal trait in the serotonin metabolism path in intrauterine growth restricted infants. Pediatr Neurol, in press.
31. Bohney JP, Feldhoff RC: Effects of nonenzymatic glycosylation and fatty acids on tryptophan binding to human serum albumin. Biochem Pharmacol 1992;43:1829-1834.
32. Sadler E, Weiner M, Buterbaugh GG: Effect of streptozotocin-induced diabetes on tryptophan oxygenase activity and brain trytophan levels in rats. Res Commun Chem Pathol Pharmacol 1983;42:37-50.
33. McCall AL, Millington W, Wurtman RI: Metabolic fuel and amino acid transport into the brain experimental diabetes mellitus. Proc Natl Acad Sci USA 1982;79:5406-5410.
34. D'Amato JR, Blue ME, Largent BL, Lynch DR, Ledbetter DJ: Ontogeny of the serotonergic projection to rat neocortex: transient expression of a dense innervation to primary sensory areas. Proc Natl Acad Sci USA 1987;84:4322-4326.
35. Bennett-Clarke CA, Chiaia NL, Rhoades RW: Contributions of raphe-cortical and thalamocortical axons to the transient somatotopic pattern of serotonin immunoreactivity in the rat cortex. Somatosens Mot Res 1997;14:27-33.
36. Morrison JH, Foote SL, Molliver ME, Bloom FE, Lidov HGW: Noradrenergic and serotonergic fibers innervate complementary layers in monkey primary visual cortex: an immunohistochemical study. Proc Natl Acad Sci USA 1982;79:2401-2405.
37. Ehlers CL, Wall TL, Chaplin RL: Long latency event-related potentials in rats: Effects of dopaminergic and serotonergic depletions. Pharmacol Biochem Behav 1991;38:789-793.
38. Lutzenberger W, Schandry R, Birbaumer N: Habituation of the components of the AEP to stimuli of different intensities;in Kimmel HD, van Olst EH, Orlebeke JF (eds): The Orienting Reflex in Humans. Hillsdale, Lawrence Erlbaum, 1979, pp 123-128.
39. Sappey MD, Calabrese G, Fein G, Hugg JW, Biggins C, Weine MW: Effect of photic stimulation on human visual cortex lactate and phosphates using 1 H and 31 P magnetic spectroscopy. J Cereb Blood Flow Metab 1992;12:584-592.
40. Kandel ER: Cellular mechanisms of learning and biological basis of individuality;in Kandel EC, Schwarts JH, Jessel TM (eds): Principles of Neural Science. New York, Elsevier, 1992, pp 1009-1031.
41. Thompson RF, Spencer WA: Habituation: a model phenomenon for the study of neuronal substrates of behavior. Psychol Rev 1966;7:16-43.
42. Lukas JH, Siegel J: Cortical mechanisms that augment or reduce evoked potentials in cats. Science 1977;198:73-75.
43. Jacobs BL, Azmitia EC: Structure and function of the brain serotonin system. Physiol Rev 1992;72:165-229.
44. Zhou FM, Hablitz JJ: Activation of serotonin receptors modulates synaptic transmission in rat cerebral cortex. J Neurophysiol 1999;82:2989-2999.
45. Uberall MA, Renner C, Edl S, Parzinger E, Wenzel D: VEP and ERP abnormalities in children and adolescents with pre-pubertal onset of insulin-dependent diabetes mellitus. Neuropediatrics 1996;27:88-93.
46. Comi G: Evoked potentials in diabetes mellitus. Clin Neurosci 1997;4:374-379.